- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Medicus Pharma Ltd: Medicus Pharma Advances Teverelix Program Towards Registrational Development Targeting High Cardiovascular-Risk Prostate Cancer Patients with Key European Submission | 527 | GlobeNewswire (Europe) |
PHILADELPHIA, June 08, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs... ► Artikel lesen | |
| 03.06. | Medicus Pharma Ltd: Medicus Pharma Advances SkinJect into Registrational Development for Gorlin Syndrome | 200 | GlobeNewswire (Europe) | PHILADELPHIA, June 03, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs... ► Artikel lesen | |
| 28.05. | Medicus Pharma secures up to $22M financing facility | 5 | Investing.com | ||
| 28.05. | Medicus Pharma Ltd: Medicus Pharma Announces $22 Million Non-Dilutive Financing | 623 | GlobeNewswire (Europe) | PHILADELPHIA, May 28, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs... ► Artikel lesen | |
| 27.05. | Medicus Pharma Ltd. - 8-K, Current Report | 6 | SEC Filings | ||
| 16.05. | New to The Street's Show #753 Airs Nationwide on Bloomberg Television Across the U.S., MENA and Latin America Featuring FreeCast, Stardust Power, Lost Soldier Oil and Gas, Virtuix Holdings, and Medicus Pharma | 1.871 | ACCESS Newswire | The show broadcasts as sponsored programming featuring TV commercials from IGC Pharma, Inc. (NYSE American:IGC), NRx Pharmaceuticals, Inc. (NASDAQ:NRXP), Medicus Pharma Ltd. (NASDAQ:MDCX), and DataVault... ► Artikel lesen | |
| 14.05. | Medicus Pharma Ltd. GAAP EPS of -$0.31 | 6 | Seeking Alpha | ||
| 14.05. | Medicus Pharma Ltd: Medicus Pharma Reports First Quarter 2026 Financial Results and Provides Corporate Update | 405 | GlobeNewswire (Europe) | PHILADELPHIA, May 14, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs... ► Artikel lesen | |
| MEDICUS PHARMA Aktie jetzt für 0€ handeln | |||||
| 14.05. | Medicus Pharma Ltd. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 06.05. | Medicus Pharma reports dose response data from skin cancer study | 11 | Investing.com | ||
| 06.05. | Medicus Pharma Ltd: Medicus Pharma Announces Results from Pre-Specified Expanded Phase 2 SKNJCT-003 Data Analysis Demonstrating Positive Dose-Response | 290 | GlobeNewswire (Europe) | PHILADELPHIA, May 06, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs... ► Artikel lesen | |
| 29.04. | Medicus Pharma Ltd. - 10-K/A, Annual Report | 1 | SEC Filings | ||
| 27.04. | Medicus Pharma Ltd: Medicus Pharma CEO meets with lawmakers on Energy & Commerce Committee on Capitol Hill | 7 | GlobeNewswire (USA) | ||
| 24.04. | Medicus Pharma Ltd. - 8-K, Current Report | - | SEC Filings | ||
| 18.04. | New to The Street to Broadcast Tonight on Bloomberg at 6:30 PM EST - Show #744 Featuring Virtuix Holdings, Neonc Technologies Holdings, Medicus Pharma, YY Group Holding, and Vivos Therapeutics | 819 | ACCESS Newswire | The show also broadcasts as sponsored programming additionally across MENA and Latin America as "Nuevo En La Calle," reaching millions of households worldwide weekly, with expanded digital distribution... ► Artikel lesen | |
| 17.04. | Medicus Pharma submits orphan drug application for skin cancer treatment | 2 | Investing.com | ||
| 17.04. | Hautkrebsbehandlung: Medicus Pharma beantragt Orphan-Drug-Status | 8 | Investing.com Deutsch | ||
| 17.04. | Medicus Pharma Ltd: Medicus Pharma Submits Orphan Drug Designation Application to U.S. FDA for SkinJect in Gorlin Syndrome | 1.535 | GlobeNewswire (Europe) | PHILADELPHIA, April 17, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs... ► Artikel lesen | |
| 15.04. | Medicus Pharma Ltd: Medicus Pharma to Present New Teverelix Data at AACE 2026 Demonstrating Long-Acting Hormone Suppression | 5 | GlobeNewswire (USA) | ||
| 15.04. | EXCLUSIVE: Penny Stock Medicus Pharma Findings Support Potential In Women's Health Pipeline | 1 | Benzinga.com |
1 2 3 4 5 Weiter >>
84 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PFIZER | 22,200 | +0,07 % | Community Rückblick: wO User zu Todesfall bei Newron Studie: "...der Rekrutierungsstop ist Formsache" | © Foto: Newron Pharmaceuticals SpAFDA-Stopp, ein Todesfall im klinischen Studienprogramm und große Hoffnungen auf den Schizophrenie-Wirkstoff Evenamide: Newron sorgt wieder für Debatten. Zwischen Zuversicht... ► Artikel lesen | |
| GILEAD SCIENCES | 106,28 | +0,97 % | Zelltherapien rücken in den Mittelpunkt: Warum Mesoblast von einem grundlegenden Wandel in der Biotechnologie profitieren könnte | ||
| ELI LILLY | 985,10 | +0,03 % | Pharma-Exodus: Eli Lilly halbiert Milliarden-Investition, Boehringer Ingelheim streicht 900 Millionen Euro | Die schlechten Nachrichten für den Investitionsstandort Deutschland reißen nicht ab. Nun gesellt sich die pharmazeutische Industrie, bislang weitgehend abgeschirmt vom industriellen Niedergang, zu einer... ► Artikel lesen | |
| TEVA | 29,000 | -0,34 % | Teva Pharmaceutical Industries Ltd: Teva Closes Acquisition of Emalex Biosciences, Strengthening Late-Stage Neuroscience Pipeline and Advancing Pivot to Growth Strategy | Ecopipam, an investigational asset for pediatric Tourette syndrome (TS), is a first-in-class selective dopamine D1 receptor antagonist with a novel mechanism of action and has received FDA Orphan Drug... ► Artikel lesen | |
| VERTEX PHARMACEUTICALS | 380,40 | +0,78 % | Vertex Pharmaceuticals Incorporated: Vertex Presents New Data on CASGEVY, Including First European Presentation of Data in Children Ages 5-11, at the European Hematology Association Congress and Announces Additional Global Regulatory Submissions | - Data from pivotal studies of CASGEVY in children ages 5-11 with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrate transformative potential in younger patients, consistent... ► Artikel lesen | |
| HAEMATO | 12,900 | 0,00 % | M1 Kliniken schließt Verkauf von Haemato Pharm ab | Die M1 Kliniken AG hat den Verkauf der Haemato Pharm GmbH über ihre Mehrheitsbeteiligung Haemato AG an die Phoenix Group mit Wirkung zum Ablauf des 31. Januar 2026 abgeschlossen. Sämtliche Vollzugsbedingungen... ► Artikel lesen | |
| EYEPOINT | 10,700 | +1,90 % | EyePoint, Inc.: EyePoint Announces Third Consecutive Positive DSMC Recommendation for Phase 3 Wet AMD Trials for DURAVYU, Building Confidence Ahead of Mid-2026 Topline Data | - LUGANO topline data on track for mid-2026, with LUCIA readout to follow shortly after - - Continued favorable safety profile observed in masked Phase 3 DURAVYU data, consistent with four previously... ► Artikel lesen | |
| QUANTUM BIOPHARMA | 3,524 | +3,22 % | Quantum BioPharma Provides Corporate Update | THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. TORONTO, June 01, 2026... ► Artikel lesen | |
| TONIX PHARMACEUTICALS | 9,958 | +4,95 % | Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Secures Second Commercial Payer Agreement for TONMYA, Expanding Total Commercial Coverage to ~52 Million U.S. Lives | Agreement with second leading group purchasing organization (GPO), effective June 1, 2026, provides access to approximately 17 million additional U.S. commercial lives (10% of the ~177 million commercial... ► Artikel lesen | |
| MEDPACE | 397,30 | -1,59 % | XETR NEW INSTRUMENTS AVAILABLE ON XETRA - 04.06.2026 | Folgende Wertpapiere werden in den Handel an folgenden Handelsplätzen (MIC Code) im Quotation Board an der Frankfurter Wertpapierbörse (FWB) aufgenommen. Die Notierung an anderen Handelsplätzen im Quotation... ► Artikel lesen | |
| ACHIEVE LIFE SCIENCES | 4,920 | -1,20 % | Achieve Life Sciences Strengthens Board and Commercial Leadership with Three Senior Appointments from Team Previously at Verona Pharma | SEATTLE and VANCOUVER, British Columbia, May 12, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Achieve and the Company) (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused... ► Artikel lesen | |
| LIGAND PHARMACEUTICALS | 220,00 | +1,85 % | Ligand Pharmaceuticals: Ligand Announces 2026 Investor Day in New York City | ||
| ALTIMMUNE | 2,290 | +1,10 % | Is Altimmune Worth Buying Ahead of 2026 Catalysts? | ||
| JAZZ PHARMACEUTICALS | 200,50 | +0,70 % | Jazz Pharmaceuticals' New Cancer Drug Drives $1.3 Billion Opportunity, Says Analyst | ||
| OPKO HEALTH | 1,220 | -3,17 % | OPKO Health, Inc.: OPKO Health Reports First Quarter 2026 Business Highlights and Financial Results | MIAMI, April 28, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three months ended March 31, 2026. Highlights from the first... ► Artikel lesen |
MEDICUS PHARMA LTD gehört der Branche Pharma an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,320 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MEDICUS PHARMA LTD finden Sie auf Wallstreet Online.